金黄色葡萄球菌
抗生素耐药性
抗菌剂
微生物学
体内
肽聚糖
沙门氏菌
细菌细胞结构
化学
细菌
抗生素
蛋白质降解
大肠杆菌
生物膜
抗药性
抗菌肽
多重耐药
葡萄球菌
细菌生长
生物
降级(电信)
青霉素结合蛋白
抗菌剂
生物化学
细菌素
蛋白质生物合成
离体
作者
Linqi Han,Wenping Huang,Xueting Pan,Ziying Fu,Hao Fan Peng,Guangjun Nie,Hai Wang
标识
DOI:10.1038/s41467-025-66221-w
摘要
Antibiotic resistance stands as a formidable global challenge to public health. Herein, we present a bacterial nanoinducer (bacNID) designed for targeted protein degradation in treating bacterial infections. Specifically, bacNID is engineered by grafting targeting peptides of MurD and SspB onto gold nanoparticles (GNPs). MurD plays a pivotal role in peptidoglycan production for cell wall synthesis, while SspB recruits SsrA-tagged proteins for degradation by ClpXP protease. The effectiveness of bacNIDs in targeted MurD degradation via ClpXP is demonstrated across both Gram-positive and Gram-negative bacterial strains. Importantly, prolonged exposure to bacNIDs does not result in the acquisition of resistance in either Staphylococcus aureus (S. aureus) or Salmonella typhimurium (S. typhimurium), even after 25 successive treatment passages. This stands in stark contrast to the rapid emergence of robust resistance observed with norfloxacin, evidenced by a 243-fold reduction in antibacterial activity against S. aureus after just 15 passages, and a 7410-fold decrease in activity against S. typhimurium over 22 passages. Moreover, the antimicrobial potential of bacNIDs is evaluated in vivo using S. aureus-infected nonhealing skin and corneal wounds. In summary, this study unveils a potent nanotechnology-driven strategy for targeted bacterial protein degradation with promising implications for in vivo antimicrobial applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI